Sleepiz AG (Ltd.), a Zürich-based startup, focuses on patient-centric disease management through seamless integration of contactless monitoring into homes. Leveraging sleep insights, our device, placed on the bedside table, operates non-contact and measures heart contractions, breathing patterns, and body motions with medical-grade accuracy. With FDA clearance for vital sign monitoring, it's the world's first non-contact device to achieve CE Class IIa certification for vital signs and sleep apnea diagnosis. Our integrated telemedicine approach offers screening, virtual consultation, therapy, and therapy control from the comfort of home, covered by existing reimbursement systems.

News

11.10.2023 FDA approval for SleepizOne+ device (startupticker.ch)
25.05.2022 ETH Spin-off Sleepiz schafft B2B-Markteintritt (startupticker.ch)
08.03.2022 Sleepiz closes Series A round at CHF 6,2 million (startupticker.ch)
27.08.2021 Sleepiz AG Raises CHF 4.4m (startupticker.ch)

Milestones/News

19.10.2020 Grant by Innosuisse
20.07.2020 ETH Spin-off
12.03.2020 ISO 13485 Certified
17.07.2019 Seal of Excellence - European Commission
29.05.2019 Seed Round

Videos and Presentations


Sleepiz Introduction